Evangeline Lilly says she has brain damage, months after fainting and hitting her head on a rock while at the beach.
Start the day smarter. Get all the news you need in your inbox each morning. At issue: the list price of insulin ...
The fierce rivalry between Novo Nordisk and Eli Lilly is alive and well, as the two companies are expected to face off with ...
Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.
Stocktwits on MSN
Eli Lilly heads toward a defining 2026 — can it stay ahead of Novo Nordisk in the GLP-1 showdown?
Novo’s oral Wegovy launch has intensified competition for Eli Lilly heading into 2026. ・Lilly’s outlook hinges on oral drug ...
The Daily Overview on MSN
Eli Lilly's surprise dividend story could be a 2026 must-own
Eli Lilly has quietly turned a blockbuster obesity and diabetes franchise into one of the market's most intriguing income ...
Investor's Business Daily on MSN
Eli Lilly lags in the weight-loss pill war. But it has a plan.
Eli Lilly stock is falling as rival Novo Nordisk hit a milestone in the area of weight-loss drugs. But Lilly has a rival drug ...
A key to the pill's success will be attracting cash-paying consumers who cannot obtain insurance coverage, a stark shift from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results